The Ability of Different Scoring Systems to Predict Mortality in Chronic Obstructive Pulmonary Disease Patients: A Prospective Cohort Study

Background: Chronic obstructive pulmonary disease (COPD) is a leading cause of mortality, therefore the prediction of mortality in COPD patients is crucial. In the current study, the abilities of different categorization systems to predict mortality in stable COPD patients from a prospective cohort were compared. Methods: The ability to predict mortality was compared in terms of discrimination by Harrell’s C (HC) index and calibration using graphical comparison among the GOLD (Global Initiative for Chronic Obstructive Lung Disease) 2011, GOLD 2017, GOLD grade, BODE (BMI, Airflow Obstruction, Dyspnea, Exercise), updated BODE, BODEx (BMI, Airflow Obstruction, Dyspnea, Exacerbation), e-BODE (Exacerbation and BODE), ADO (Age, Dyspnea, Airflow Obstruction), COPD prognostic index (CPI), and simplified/optimized B-AE-D (BMI, Acute Exacerbation, Dyspnea) indexes. Results: The study included 520 patients, of whom 63 died during a median 40-month follow-up period. Combined prediction systems exhibited higher discrimination properties than single predictors. The CPI exhibited the highest with a HC of 0.768, followed by the simplified B-AE-D (HC 0.761), ADO (HC 0.760), and optimized B-AE-D (HC 0.756). The BODE and its variants other than the ADO exhibited relatively lower HCs (0.656–0.705), and GOLD exhibited the lowest discrimination ability among the combined indices (HCs 0.628–0.637). Subjective symptom questionnaires such as the modified Medical Research Council (mMRC) scale (HC 0.693) and SGRQ (HC 0.679) exhibited the highest ability to predict mortality among the single indices. Conclusion: The ADO, simplified B-AE-D, optimized B-AE-D, and GOLD 2017 exhibited good calibration properties, but the CPI did not. The simplified and optimized B-AE-Ds and the ADO index had good discrimination and calibration properties for the prediction of mortality in stable COPD patients.

[1]  Meilan K. Han,et al.  Large-scale external validation and comparison of prognostic models: an application to chronic obstructive pulmonary disease , 2018, BMC Medicine.

[2]  E. Horváth-Puhó,et al.  Prediction of mortality in patients with chronic obstructive pulmonary disease with the new Global Initiative for Chronic Obstructive Lung Disease 2017 classification: a cohort study. , 2018, The Lancet. Respiratory medicine.

[3]  B. Celli,et al.  Comparison of the 2017 and 2015 Global Initiative for Chronic Obstructive Lung Disease Reports: Impact on Grouping and Outcomes , 2017, American journal of respiratory and critical care medicine.

[4]  A. Briggs,et al.  Prediction models for exacerbations in different COPD patient populations: comparing results of five large data sources , 2017, International journal of chronic obstructive pulmonary disease.

[5]  G. Guyatt,et al.  Discrimination and Calibration of Clinical Prediction Models: Users’ Guides to the Medical Literature , 2017, JAMA.

[6]  J. Soriano,et al.  Prognostic assessment in COPD without lung function: the B-AE-D indices , 2016, European Respiratory Journal.

[7]  Michael J Pencina,et al.  Evaluating Discrimination of Risk Prediction Models: The C Statistic. , 2015, JAMA.

[8]  M. Puhan,et al.  The ADO Index as a Predictor of Two-Year Mortality in General Practice-Based Chronic Obstructive Pulmonary Disease Cohorts , 2014, Respiration.

[9]  P. Royston,et al.  External validation of a Cox prognostic model: principles and methods , 2013, BMC Medical Research Methodology.

[10]  Morten Dahl,et al.  Prediction of the clinical course of chronic obstructive pulmonary disease, using the new GOLD classification: a study of the general population. , 2012, American journal of respiratory and critical care medicine.

[11]  Roger Newson,et al.  Comparing the Predictive Powers of Survival Models Using Harrell's C or Somers’ D , 2010 .

[12]  Ulrike Held,et al.  Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index , 2009, The Lancet.

[13]  M. Martínez-García,et al.  Severe exacerbations and BODE index: two independent risk factors for death in male COPD patients. , 2009, Respiratory medicine.

[14]  Yvonne Vergouwe,et al.  Prognosis and prognostic research: what, why, and how? , 2009, BMJ : British Medical Journal.

[15]  D. Mannino,et al.  Development and validation of a prognostic index for health outcomes in chronic obstructive pulmonary disease. , 2008, Archives of internal medicine.

[16]  D. Mannino,et al.  Changing the burden of COPD mortality , 2006, International journal of chronic obstructive pulmonary disease.

[17]  D. Halpin,et al.  Chronic obstructive pulmonary disease: the disease and its burden to society. , 2006, Proceedings of the American Thoracic Society.

[18]  M. Martínez-García,et al.  Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease , 2005, Thorax.

[19]  Ciro Casanova,et al.  The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. , 2004, The New England journal of medicine.

[20]  A. Youk,et al.  Lymphohaematopoietic cancer risk among chemical workers exposed to benzene , 2004, Occupational and Environmental Medicine.

[21]  B. Celli,et al.  The 6‐min walk distance: change over time and value as a predictor of survival in severe COPD , 2004, European Respiratory Journal.

[22]  Jordi Alonso,et al.  Health-related quality of life and mortality in male patients with chronic obstructive pulmonary disease. , 2002, American journal of respiratory and critical care medicine.

[23]  Toru Oga,et al.  Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. , 2002, Chest.

[24]  D. Hosmer,et al.  A review of goodness of fit statistics for use in the development of logistic regression models. , 1982, American journal of epidemiology.

[25]  H. Thompson,et al.  Prognosis in chronic obstructive pulmonary disease. , 1973, The American review of respiratory disease.